Rescuing the attentional performance of rats with cholinergic losses by the M1 positive allosteric modulator TAK-071.

These findings suggest that TAK-071 may benefit the attentional performance of patients with partial cholinergic losses and specifically in situations that tax top-down, or goal-driven, attentional control.